Key Takeaways on Enhancing Outcomes for mNSCLC Without Targetable Driver Mutations
The panel provides insights on enhancing outcomes for patients with metastatic non-small cell lung cancer without targetable driver mutations.
Overcoming Immunotherapy Resistance: Identifying Non-Responders and Novel Approaches
The panel shares clinical practices for overcoming immunotherapy resistance in patients with non-small cell lung cancer.
Clinical Factors Impacting Immunotherapy Response and Optimizing Patient Selection
A panel of experts on non-small cell lung cancer outline factors that impact how well patients respond to immunotherapy.
